Opus Genetics (IRD) Return on Assets (2011 - 2026)
Opus Genetics' (IRD) quarterly Return on Assets came in at 0.02% in Q1 2026, little changed year-on-year from 0.02% in Q1 2025, and down 81.81% on a QoQ basis from 0.01% in Q4 2025.
Opus Genetics (IRD) Return on Assets (2011 - 2026) Analysis & Trends
Opus Genetics (IRD) has 16 years of Return on Assets data on file, last reported at 0.02% in Q1 2026.
- On a quarterly basis, Return on Assets changed 0.0% year-over-year to 0.02% in Q1 2026; TTM through Mar 2026 was 0.02%, a 0.0% change from a year earlier, with the FY2025 full-year figure at 0.01%, changed 0.0% from the prior year.
- Return on Assets for Q1 2026 stood at 0.02%, down from 0.01% in the prior quarter.
- Over the last five years, Return on Assets for IRD reached as high as 0.01% in Q3 2023 and fell as low as 0.02% in Q3 2025.
- Historically, Return on Assets has averaged 0.01% across 5 years, with a median of 0.01% in 2025.
- Across the five-year window, Return on Assets advanced 3 bps in 2022 and fell 1 bps in 2023, its largest moves.
- Year by year, Return on Assets stood at 0.01% in 2022, then tumbled by 133 bps to 0.0% in 2023, then plunged by 706 bps to 0.01% in 2024, then jumped by 39 bps to 0.01% in 2025, then plunged by 82 bps to 0.02% in 2026.
- Per Business Quant data, the three most recent Return on Assets figures were 0.02% in Q1 2026, 0.01% in Q4 2025, and 0.02% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -0.69% |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -0.01% |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.00% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -0.80% |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 0.00% |
| 10 | Opus Genetics | 263.72 Mn | 203.72 Mn | - | -0.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.02% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.02% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.01% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.01% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.02% |
| Sep 30, 2021 | -0.03% |
| Jun 30, 2021 | -0.04% |